跳至主要内容
临床试验/IRCT2014121511019N4
IRCT2014121511019N4已完成2 期

Assessment of Vitamin D effect in compare to placebo in decreasing of leiomyoma size in patients with uterine leiomyoma

Vice Chancellor for Research and Technology, Semnan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 45 years(—)
性别
Female

入选标准

  • Age between 20 and 45 years, having one or more uterine fibroids, the largest be 3 cm based on ultrasound, vitamin D and 25-hydroxyvitamin D concentrations lower than 75 nmol per liter or 30 ng/ml.
  • Exclusion criteria: Leiomyoma with acute symptoms which requiring to immediate surgical intervention, liver or kidney disorders, cancer of the uterus, cervix and ovarian, adnexal mass, endometrial lesions such as polyps on ultrasound, use of hormonal therapy in the last three months, pregnancy, lactation or the desire to become pregnant during the study period, delivery within the last six months, uterine myoma in size more than 12 cm, the size of the uterine leiomyoma more than 20 weeks, history of gastrointestinal problems, especially malabsorption syndrome.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research and Technology, Semnan University of Medical Sciences

相似试验

Vitamin D or placebo in treatment of uterine... | 临床试验